EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Overexpression of Mitochondrial ALDH2 in Coronary Endothelial Cells Mitigates HFpEF in a Diabetic Mouse Model

Guodong Pan iD, Bipradas Roy iD, Emmanuel Oppong Yeboah iD, Thomas Lanigan, Roland Hilgarth, Rajarajan A Thandavarayan iD, Michael C Petriello iD, Shailendra Giri iD, Suresh Selvaraj Palaniyandi

Biomolecules · 16.07.2025 · 15 (7) · 1029

DOI: 10.3390/biom15071029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 16.07.2025. Verfasst von Guodong Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Endothelial Cells, Heart Failure, Mitochondria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henry Ford Health System, NIEHS NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) has become an epidemic, with a prevalence of ~7 million cases in the USA. Despite accounting for nearly 50% of all HF cases, heart failure with a preserved ejection fraction (HFpEF) remains challenging to treat. Common pathophysiological mechanisms in HFpEF include oxidative stress, microvascular dysfunction, and chronic unresolved inflammation. Our lab focuses on oxidative stress-mediated cellular dysfunction, particularly the toxic effects of lipid peroxidation products like 4-hydroxy-2-nonenal (4HNE). Aldehyde dehydrogenase 2 (ALDH2), a mitochondrial enzyme, plays a vital role in detoxifying 4HNE and thereby protecting the heart against pathological stress. ALDH2 activity is reduced in various metabolic stress-mediated cardiac pathologies. The dysfunction of coronary vascular endothelial cells (CVECs) is critical in initiating HFpEF development. Thus, we hypothesized that ectopic overexpression of ALDH2 in CVECs could mitigate metabolic stress-induced HFpEF pathogenesis. In this study, we tested the efficacy of intracardiac injections of the ALDH2 gene into CVECs in db/db mice—a model of obesity-induced type 2 diabetes mellitus (T2DM)—and their controls, db/m mice, by injection with ALDH2 constructs (AAV9-VE-cadherin-hALDH2-HA tag-P2A) or control constructs (AAV9-VE-cadherin-HA tag-P2A-eGFP). We found that intracardiac ALDH2 gene transfer increased ALDH2 levels specifically in CVECs compared to other myocardial cells. Additionally, we observed increased ALDH2 levels and activity, along with decreased 4HNE adducts, in the hearts of mice receiving ALDH2 gene transfer compared to control GFP transfer. Furthermore, ALDH2 gene transfer to CVECs improved diastolic function compared to GFP control alone. In conclusion, ectopic ALDH2 expression in CVECs can contribute, at least partially, to the amelioration of HFpEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde Dehydrogenase, MitochondrialEndothelial CellsHeart FailureMitochondriaDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AnimalsMiceDisease Models, AnimalMaleStroke VolumeCoronary VesselsOxidative StressMice, Inbred C57BL

Stichwörter der Autor:innen

4-hydroxy-2-nonenal (4HNE)adeno-associated virus serotype 9 expressing vascular endothelial (VE)-cadherinaldehyde dehydrogenase 2 (ALDH2)coronary vascular endothelial cells (CVECs)gene transferheart failure with preserved ejection fraction (HFpEF)type 2 diabetes mellitus (T2DM)

Substanzen

Aldehyde Dehydrogenase, MitochondrialALDH2 protein, mouse

Autor:innen und Institutionen

  • Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA.
  • Department of Physiology, Wayne State University, Detroit, MI 48202, USA.
  • Vector Core, Biomedical Research Core Facilities, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
  • Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX 77030, USA.
  • Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.
  • Department of Pharmacology, Wayne State University, Detroit, MI 48202, USA.

ORCID-Profile: Guodong Pan, Bipradas Roy, Emmanuel Oppong Yeboah, Rajarajan A Thandavarayan, Michael C Petriello, Shailendra Giri

Förderung

  • Henry Ford Health System
  • NIEHS NIH HHS
  • American Heart Association
  • MDRC-National Institute of Diabetes and Digestive and Kidney Diseases
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Environmental Health Sciences

Zitieren

APA

Pan, G., Roy, B., Yeboah, E. O., Lanigan, T., Hilgarth, R., Thandavarayan, R. A., Petriello, M. C., Giri, S., & Palaniyandi, S. S. (2025). Targeted Overexpression of Mitochondrial ALDH2 in Coronary Endothelial Cells Mitigates HFpEF in a Diabetic Mouse Model. Biomolecules, 15(7), 1029. https://doi.org/10.3390/biom15071029

Vancouver

Pan G, Roy B, Yeboah EO, Lanigan T, Hilgarth R, Thandavarayan RA, et al. Targeted Overexpression of Mitochondrial ALDH2 in Coronary Endothelial Cells Mitigates HFpEF in a Diabetic Mouse Model. Biomolecules. 2025;15(7):1029. doi:10.3390/biom15071029

BibTeX
@article{Pan2025,
  author = {Pan, Guodong and Roy, Bipradas and Yeboah, Emmanuel Oppong and Lanigan, Thomas and Hilgarth, Roland and Thandavarayan, Rajarajan A and Petriello, Michael C and Giri, Shailendra and Palaniyandi, Suresh Selvaraj},
  title = {Targeted Overexpression of Mitochondrial ALDH2 in Coronary Endothelial Cells Mitigates HFpEF in a Diabetic Mouse Model},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {1029},
  doi = {10.3390/biom15071029}
}
Kostenlos starten →